Teyi Pharmaceutical Group Co Ltd (002728) — Net Asset Quality Index
Teyi Pharmaceutical Group Co Ltd (002728) has a Net Asset Quality Index of 79.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.33 Billion minus total liabilities of CN¥480.81 Million yields net assets of CN¥1.85 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Teyi Pharmaceutical Group Co Ltd (002728) financial obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Teyi Pharmaceutical Group Co Ltd Net Asset Quality Index Over Time (2009–2025)
This chart shows how Teyi Pharmaceutical Group Co Ltd's Net Asset Quality Index has evolved across 17 annual periods from 2009 to 2025. As of March 2026, the index stands at 79.3%, representing net assets of CN¥1.85 Billion against total assets of CN¥2.33 Billion CNY. For live market cap and overall valuation, see Teyi Pharmaceutical Group Co Ltd stock valuation.
Annual Net Asset Quality Index for Teyi Pharmaceutical Group Co Ltd (2009–2025)
The table below presents the year-by-year Net Asset Quality Index for Teyi Pharmaceutical Group Co Ltd from 2009 to 2025, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 002728 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 79.5% | CN¥1.84 Billion | CN¥2.31 Billion | CN¥472.69 Million | ▲ +6.0 pp |
| 2024 | 73.5% | CN¥1.76 Billion | CN¥2.40 Billion | CN¥635.94 Million | ▼ -6.5 pp |
| 2023 | 80.0% | CN¥2.01 Billion | CN¥2.51 Billion | CN¥501.95 Million | ▲ +24.9 pp |
| 2022 | 55.1% | CN¥1.40 Billion | CN¥2.55 Billion | CN¥1.14 Billion | ▼ -5.9 pp |
| 2021 | 61.1% | CN¥1.26 Billion | CN¥2.07 Billion | CN¥804.51 Million | ▲ +13.2 pp |
| 2020 | 47.9% | CN¥1.08 Billion | CN¥2.26 Billion | CN¥1.18 Billion | ▼ -3.2 pp |
| 2019 | 51.1% | CN¥1.15 Billion | CN¥2.26 Billion | CN¥1.10 Billion | ▼ -2.7 pp |
| 2018 | 53.7% | CN¥1.11 Billion | CN¥2.07 Billion | CN¥956.39 Million | ▼ -0.3 pp |
| 2017 | 54.1% | CN¥1.04 Billion | CN¥1.93 Billion | CN¥886.14 Million | ▼ -1.2 pp |
| 2016 | 55.3% | CN¥886.57 Million | CN¥1.60 Billion | CN¥716.61 Million | ▲ +5.0 pp |
| 2015 | 50.3% | CN¥804.30 Million | CN¥1.60 Billion | CN¥793.78 Million | ▼ -38.8 pp |
| 2014 | 89.1% | CN¥735.64 Million | CN¥825.60 Million | CN¥89.96 Million | ▲ +11.9 pp |
| 2013 | 77.2% | CN¥350.14 Million | CN¥453.54 Million | CN¥103.40 Million | ▲ +3.7 pp |
| 2012 | 73.5% | CN¥285.34 Million | CN¥388.22 Million | CN¥102.88 Million | ▼ -6.1 pp |
| 2011 | 79.6% | CN¥225.51 Million | CN¥283.21 Million | CN¥57.71 Million | ▲ +12.0 pp |
| 2010 | 67.6% | CN¥170.81 Million | CN¥252.73 Million | CN¥81.92 Million | ▲ +13.2 pp |
| 2009 | 54.4% | CN¥103.18 Million | CN¥189.65 Million | CN¥86.47 Million | — |